We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Curevac
30 own
10 watching
Current Price
$0
$0.25
(2.74%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,704.67M
52-Week High
19.31
52-Week Low
5.63
Average Volume
0.09M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,704.67M52-Week High19.3152-Week Low5.63Average Volume0.09MDividend Yield--P/E Ratio--What does the Curevac do?
We are a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. Our vision is to revolutionize medicine and open new avenues for developing therapies by enabling the body to make its own drugs. --- Our principal executive offices are located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany. Our telephone number at this address is +49 7071 98830. Our principal website is www.curevac.com.
Read More
News & Events about Curevac.
Accesswire
3 months ago
TÜBINGEN, GERMANY / BOSTON, MA / ACCESSWIRE / February 7, 2023 / CureVac N.V. (NASDAQ:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced today that it intends...
Accesswire
4 months ago
CureVac recognized as a Top 100 innovator in acknowledgment of the company's innovative strength and extensive intellectual property portfolioThe company holds one of broadest intellectual property portfolios in mRNA technologyTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 31...
Accesswire
4 months ago
Continued technology platform validation with extended preliminary data from older adults in ongoing Phase 1 studies in COVID-19 and fluCOVID-19: monovalent modified mRNA construct CV0501 successfully boosted antibody titers against BA.1 and ancestral variants in adults age ≥65Flu...
Invezz News
4 months ago
Shares of CureVac BV (NASDAQ: CVAC) have already almost doubled year-to-date but a UBS analyst says the stock still has a lot more room to the upside. CureVac stock could gain close to 100% On Thursday, Eliana Merle turned bullish on the biopharmaceutical firm and sharply increased her price ...
Frequently Asked Questions
Frequently Asked Questions
What is Curevac share price today?
Can Indians buy Curevac shares?
How can I buy Curevac shares from India?
Can Fractional shares of Curevac be purchased?
What are the documents required to start investing in Curevac stocks?
What is today’s traded volume of Curevac?
What is today’s market capitalisation of Curevac?
What is the 52-Week High and Low Range of Curevac?
What percentage is Curevac down from its 52-Week High?
What percentage is Curevac up from its 52-Week Low?
Current Price
$0
$0.25
(2.74%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.